Medical Economics July 26, 2024
Kenneth E. Thorpe, PhD

For some seniors living with chronic diseases, one particular reform may actually lead to higher out-of-pocket costs

Healthcare costs are one of Americans’ top concerns as we head into election season, according to a Pew Research Center poll.

President Joe Biden has worked hard to address this issue — and has delivered for America’s most vulnerable. His historic Inflation Reduction Act caps insulin costs, limits out-of-pocket drug spending to $2,000 annually, and allows seniors to spread their pharmacy bills evenly throughout the year. Collectively, these reforms are a major step forward for healthcare affordability.

The IRA also directs Medicare to negotiate the price of certain medicines for the first time ever. Unfortunately, for some seniors living with chronic diseases, this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article